ICYMI: IGT Chair Erik Paulsen and Scientific, Academic and Medical Council Chair Donna M. Christensen on the Future of Gene Therapy

msevcik1
Dec 3, 2024
1 min read

IGT leaders recently penned a piece exploring the strides being made in gene therapy and highlighting the ongoing challenges that must be addressed to bring these life-changing treatments to more patients.

Read the op-ed in RealClear Health here: https://www.realclearhealth.com/blog/2024/11/28/continued_progress_is_needed_to_make_gene_therapy_a_reality_for_patients_1075158.html

Recent Posts

See All

Reflecting on Five Years of IGT: Our Commitment to Patients and Innovation

As we commemorate the fifth anniversary of the Institute for Gene Therapies (IGT) today, I want to take a look back at the strides we've...

The Federal Newborn Screening Program at a Crossroads

As Newborn Screening Awareness Month concludes, IGT applauds the tireless work of advocates who dedicate themselves 365 days of the year...

What Newborn Screening Really Means in the Sickle Cell Disease Community and Beyond

Author: Andrea Matthews, Founder, Children’s Sickle Cell Foundation, Inc. Newborn screening (NBS) is an important public health measure...

ICYMI: IGT Chair Erik Paulsen and Scientific, Academic and Medical Council Chair Donna M. Christensen on the Future of Gene Therapy

Recent Posts

Comments

Get In Touch